| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-4419-0901-5_7 |
| P8608 | Fatcat ID | release_mi5gihlmdjhndkv6xanozfjhku |
| P932 | PMC publication ID | 3367411 |
| P698 | PubMed publication ID | 19799114 |
| P5875 | ResearchGate publication ID | 26865464 |
| P50 | author | Alberto Mantovani | Q22069468 |
| Barbara Bottazzi | Q42306567 | ||
| Cecilia Garlanda | Q60001307 | ||
| P2093 | author name string | Alok Agrawal | |
| Prem Prakash Singh | |||
| P2860 | cites work | Calcium-dependent and -independent binding of the pentraxin serum amyloid P component to glycosaminoglycans and amyloid proteins: enhanced binding at slightly acid pH | Q73370299 |
| Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene | Q73497761 | ||
| Difference in binding of killed and live Streptococcus pneumoniae serotypes by C-reactive protein | Q74011003 | ||
| C-reactive protein induces signaling through Fc gamma RIIa on HL-60 granulocytes | Q77522454 | ||
| IMMUNOLOGIC STUDIES ON A PROTEIN EXTRACTED FROM HUMAN SECONDARY AMYLOID | Q78401653 | ||
| C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R | Q78626014 | ||
| Ultrasensitive confocal fluorescence microscopy of C-reactive protein interacting with FcgammaRIIa | Q80866442 | ||
| Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood | Q80879374 | ||
| Inhibition of platelet-activating factor by rabbit C-reactive protein | Q93612777 | ||
| Regulation of complement activation by C-reactive protein | Q22010264 | ||
| Molecular chaperone properties of serum amyloid P component | Q22254102 | ||
| Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component | Q24294475 | ||
| The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties | Q24320322 | ||
| Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis | Q24562844 | ||
| C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity | Q24675774 | ||
| SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS | Q24684141 | ||
| The physiological structure of human C-reactive protein and its complex with phosphocholine | Q27618638 | ||
| Structure of pentameric human serum amyloid P component | Q27731194 | ||
| Three dimensional structure of human C-reactive protein | Q27732605 | ||
| Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene | Q28246156 | ||
| Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria | Q28362275 | ||
| Isolation and characterization of C-reactive protein and serum amyloid P component in the rat | Q28582755 | ||
| PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages | Q28588062 | ||
| Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum | Q28610077 | ||
| Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. | Q30475959 | ||
| Topology and structure of the C1q-binding site on C-reactive protein | Q32133439 | ||
| Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections | Q33217837 | ||
| Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice | Q33591685 | ||
| The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis | Q33598362 | ||
| Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity | Q33702069 | ||
| C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance | Q38596519 | ||
| Transformation of Leishmania mexicana metacyclic promastigotes to amastigote-like forms mediated by binding of human C-reactive protein. | Q38899574 | ||
| C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI). | Q38912827 | ||
| C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. | Q38957644 | ||
| Lipopolysaccharide (LPS)-binding synthetic peptides derived from serum amyloid P component neutralize LPS. | Q39510738 | ||
| Expression of C-reactive protein in the human respiratory tract | Q39518908 | ||
| Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis | Q40425734 | ||
| DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. | Q40509762 | ||
| Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. | Q33874500 | ||
| Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease | Q33895058 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells | Q33927564 | ||
| Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis | Q33947428 | ||
| Chromatin-independent binding of serum amyloid P component to apoptotic cells | Q34083159 | ||
| Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients | Q34083517 | ||
| PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation | Q34106947 | ||
| Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation | Q34128052 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response | Q34159058 | ||
| Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells | Q34180480 | ||
| Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. | Q34184675 | ||
| C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids | Q34191416 | ||
| Multiple ligand binding sites on domain seven of human complement factor H. | Q34257502 | ||
| PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization | Q34302929 | ||
| TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins | Q34305784 | ||
| Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. | Q34324823 | ||
| C-reactive Protein | Q34344434 | ||
| Human C-reactive protein: expression, structure, and function | Q34353024 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites | Q34380249 | ||
| IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection | Q34395156 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. | Q34450228 | ||
| The pattern recognition receptor PTX3 is recruited at the synapse between dying and dendritic cells, and edits the cross-presentation of self, viral, and tumor antigens | Q34451375 | ||
| Mouse C-reactive protein. Generation of cDNA clones, structural analysis, and induction of mRNA during inflammation | Q34458823 | ||
| Interferon-gamma inhibits expression of the long pentraxin PTX3 in human monocytes | Q34461848 | ||
| The antimicrobial activity of C-reactive protein | Q34552829 | ||
| Serum amyloid P component enhances induction of murine amyloidosis | Q34743748 | ||
| Recognition and clearance of apoptotic cells: a role for complement and pentraxins | Q35077167 | ||
| C-reactive protein protects against preerythrocytic stages of malaria | Q35089727 | ||
| Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure | Q35501399 | ||
| Serum amyloid P component-induced cell death in primary cultures of rat cerebral cortex | Q72370527 | ||
| Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive protein | Q72658152 | ||
| Binding of serum amyloid P component to heparin in human serum | Q72773916 | ||
| Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation | Q73083027 | ||
| Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs | Q73365845 | ||
| C-reactive protein binding to murine leukocytes requires Fc gamma receptors | Q73368189 | ||
| Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis | Q40576794 | ||
| Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component | Q41392379 | ||
| The interaction of C-reactive protein and serum amyloid P component with nuclear antigens | Q41438966 | ||
| Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid | Q41517888 | ||
| Internalization and degradation of receptor bound C-reactive protein by U-937 cells: induction of H2O2 production and tumoricidal activity | Q41657017 | ||
| Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells | Q41669884 | ||
| Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus | Q41851496 | ||
| Pentraxin binding to isolated rat liver nuclei | Q41865112 | ||
| Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry | Q41877441 | ||
| Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis | Q42226555 | ||
| Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoter | Q42483005 | ||
| Identification of a polypeptide sequence that mediates nuclear localization of the acute phase protein C-reactive protein | Q42634697 | ||
| Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages | Q42804106 | ||
| THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS. | Q42812366 | ||
| Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin | Q42938095 | ||
| Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein | Q43002262 | ||
| Genetic and functional analysis of the phosphorylcholine moiety of commensal Neisseria lipopolysaccharide | Q43606585 | ||
| Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration | Q43694176 | ||
| Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors | Q44021529 | ||
| A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide | Q44129524 | ||
| Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages | Q44278532 | ||
| Lectin specificity and binding characteristics of human C-reactive protein | Q44393824 | ||
| Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells | Q44600227 | ||
| Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence | Q44810016 | ||
| The amino acid sequence of Limulus C-reactive protein. Evidence of polymorphism. | Q44961175 | ||
| Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells | Q44985116 | ||
| TSG-14 transgenic mice have improved survival to endotoxemia and to CLP-induced sepsis. | Q45059195 | ||
| Native and modified C-reactive protein bind different receptors on human neutrophils | Q45098952 | ||
| Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? | Q46513399 | ||
| No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. | Q46513410 | ||
| An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor | Q46588867 | ||
| The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation | Q47265306 | ||
| Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. | Q48032486 | ||
| Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility | Q48859172 | ||
| Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide | Q49164699 | ||
| Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease | Q50114041 | ||
| A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. | Q50129215 | ||
| Studies of gene expression in human cumulus cells indicate pentraxin 3 as a possible marker for oocyte quality. | Q50663516 | ||
| Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. | Q51817209 | ||
| Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component | Q53200598 | ||
| Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. | Q53653886 | ||
| Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. | Q53662602 | ||
| Binding specificity of mouse serum amyloid P-component for fibronectin. | Q53762920 | ||
| Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. | Q53895846 | ||
| Inducible expression of the long pentraxin PTX3 in the central nervous system. | Q54051253 | ||
| Enhancement of human peripheral blood monocyte respiratory burst activity by aggregated C-reactive protein. | Q54539056 | ||
| Human renal epithelial cells produce the long pentraxin PTX3. | Q54683498 | ||
| Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity | Q56595317 | ||
| Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction | Q56942827 | ||
| Follicular Fuid Levels of the Long Pentraxin PTX3 | Q56942835 | ||
| Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: stimulation by IL-10 and inhibition by IFN- | Q56942888 | ||
| Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA) | Q56943278 | ||
| Dissociation of Serum Amyloid P from C4b-Binding Protein and Other Sites by Lactic Acid: Potential Role of Lactic Acid in the Regulation of Pentraxin Function | Q57225366 | ||
| Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein | Q60359149 | ||
| Native Human Serum Amyloid P Component is a Single Pentamer | Q63729457 | ||
| A membrane-associated form of C-reactive protein is the galactose-specific particle receptor on rat liver macrophages | Q67267450 | ||
| Primary structure of human C-reactive protein | Q67469036 | ||
| Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse anti-phosphorylcholine myeloma serum | Q67600115 | ||
| Mediation of CRP-dependent phagocytosis through mouse macrophage Fc-receptors | Q67697736 | ||
| Localizing of C-reactive protein in synovium of patients with rheumatoid arthritis | Q67708757 | ||
| Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins | Q67897567 | ||
| Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species | Q67898158 | ||
| Serum amyloid P component binds to histones and activates the classical complement pathway | Q67927321 | ||
| Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein | Q67956957 | ||
| Amyloid P component | Q68051688 | ||
| C-reactive protein (CRP) in haemolymph of a mollusc, Achatina fulica Bowdich | Q68624623 | ||
| Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria | Q68754756 | ||
| Binding of C-reactive protein to Aspergillus fumigatus fractions | Q68861933 | ||
| C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas | Q68987469 | ||
| Binding of human C-reactive protein (CRP) to plasma fibronectin occurs via the phosphorylcholine-binding site | Q69045596 | ||
| Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor | Q69335713 | ||
| Inhibition of fibrin polymerization by serum amyloid P component and heparin | Q69411350 | ||
| Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein | Q69564927 | ||
| Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization | Q69939133 | ||
| C-reactive protein binds leishmanial excreted factors | Q69939648 | ||
| Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors | Q69965580 | ||
| Binding of C-reactive protein to human polymorphonuclear leukocytes: evidence for association of binding sites with Fc receptors | Q70018727 | ||
| Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingom | Q70046050 | ||
| C-reactive protein inhibits binding of platelet-activating factor to human platelets | Q70217370 | ||
| Rat resistance to schistosomiasis: platelet-mediated cytotoxicity induced by C-reactive protein | Q70275106 | ||
| Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice | Q70289906 | ||
| Receptor-ligand interactions between serum amyloid P component and model soluble immune complexes | Q70468531 | ||
| Binding of C-reactive protein to chromatin and nucleosome core particles. A possible physiological role of C-reactive protein | Q70480310 | ||
| Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q | Q70522066 | ||
| Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models | Q70577132 | ||
| Binding reactivity of C-reactive protein for polycations. II. Modulatory effects of calcium and phosphocholine | Q70912782 | ||
| Characterization of the binding of serum amyloid P to type IV collagen | Q71143415 | ||
| Binding of fibronectin by the acute phase reactant C-reactive protein | Q71260800 | ||
| Site-directed mutagenesis of the phosphocholine-binding site of human C-reactive protein: role of Thr76 and Trp67 | Q71929955 | ||
| C-reactive protein binds to Fc gamma RI in transfected COS cells | Q71961266 | ||
| Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice | Q71997750 | ||
| Specificity of the binding interaction between human serum amyloid P-component and immobilized human C-reactive protein | Q72331966 | ||
| C-reactive protein and cardiovascular disease: new insights from an old molecule | Q35562701 | ||
| Inflammation and atherosclerosis: role of C-reactive protein in risk assessment | Q35721270 | ||
| Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury | Q35748031 | ||
| Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis | Q35817146 | ||
| Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen | Q35850904 | ||
| Structural and functional anatomy of the globular domain of complement protein C1q. | Q35896873 | ||
| Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia | Q36050745 | ||
| CRP after 2004. | Q36097479 | ||
| The liver as the site of C-reactive protein formation | Q36267987 | ||
| Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera | Q36273294 | ||
| A protease‐sensitive site in the proposed Ca2+‐binding region of human serum amyloid P component and other pentraxins | Q36277650 | ||
| Binding of human C-reactive protein to bacteria | Q36336394 | ||
| Pentraxins as a key component of innate immunity | Q36339092 | ||
| C-reactive protein is protective against Streptococcus pneumoniae infection in mice | Q36345931 | ||
| Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein | Q36346658 | ||
| Amyloidosis and female protein in the Syrian hamster. Concurrent regulation by sex hormones | Q36350865 | ||
| The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. | Q36375211 | ||
| C-reactive protein: a molecule composed of subunits | Q36378167 | ||
| Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein | Q36400340 | ||
| Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade | Q36403583 | ||
| Serum amyloid P-component-induced enhancement of macrophage listericidal activity | Q37027176 | ||
| Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist | Q37281358 | ||
| Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection | Q37281363 | ||
| Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications | Q37285802 | ||
| Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains | Q37417488 | ||
| Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins) | Q37582607 | ||
| Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals | Q37598729 | ||
| Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis | Q37652507 | ||
| Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis | Q38307556 | ||
| Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation | Q38314378 | ||
| Structure and significance of N-linked sugar unit of human serum amyloid P component | Q38341786 | ||
| Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter | Q38349770 | ||
| Interactions between rat C-reactive protein and adult Hymenolepis diminuta | Q38556195 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pattern recognition | Q378859 |
| P304 | page(s) | 98-116 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Advances in Experimental Medicine and Biology | Q4686385 |
| P1476 | title | Pattern recognition by pentraxins | |
| P478 | volume | 653 |
| Q47343441 | Amniotic fluid pentraxins: Potential early markers for identifying intra-amniotic inflammatory complications in preterm pre-labor rupture of membranes |
| Q37747141 | Anti-inflammatory actions of serine protease inhibitors containing the Kunitz domain |
| Q39283041 | Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies |
| Q35073552 | Atherosclerosis-Related Functions of C-Reactive Protein |
| Q38472979 | Biological actions of pentraxins |
| Q57969517 | Biomimetic Interfaces Reveal Activation Dynamics of C-Reactive Protein in Local Microenvironments |
| Q35823366 | Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology. |
| Q37076044 | C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study |
| Q45741165 | CRP and SAP from different species have different membrane ligand specificities |
| Q35975357 | Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehyde |
| Q50078106 | Comparative analysis of microbial sensing molecules in mucosal tissues with aging |
| Q37859539 | Complement and non-complement activating functions of C1q: a prototypical innate immune molecule |
| Q37417484 | Computational analysis of C-reactive protein for assessment of molecular dynamics and interaction properties. |
| Q58730384 | Do Pentraxins Bind to Fungi in Invasive Human Gastrointestinal Candidiasis? |
| Q35596648 | Expression, crystallization and preliminary crystallographic analysis of C-reactive protein from zebrafish |
| Q40161972 | Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation |
| Q36232242 | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation |
| Q34963775 | Heme interacts with c1q and inhibits the classical complement pathway |
| Q34385354 | Hepatic transcriptome analysis of inter-family variability in flesh n-3 long-chain polyunsaturated fatty acid content in Atlantic salmon |
| Q33736978 | High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses |
| Q44277866 | High-sensitivity CRP in opiate addiction: relative and age-dependent elevations |
| Q36086772 | Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6 |
| Q92187396 | Hypoxia and Inflammation as a Consequence of β-Fibril Accumulation: A Perspective View for New Potential Therapeutic Targets |
| Q85175286 | Increase in tissue and circulating pentraxin3 levels in patients with aortic valve stenosis |
| Q26768520 | Inflammation and its role in age-related macular degeneration |
| Q38881720 | Interactions between Trichinella spiralis infection and induced colitis in mice |
| Q89687402 | Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis? |
| Q41973219 | LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE-carrying lipoproteins |
| Q82436004 | Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury |
| Q39160620 | Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis. |
| Q57158373 | Monomeric C-Reactive Protein and Cerebral Hemorrhage: From Bench to Bedside |
| Q36106594 | Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter |
| Q37696715 | Overview of the immune response |
| Q85050971 | Pentraxin 3 Values During Normal Pregnancy |
| Q40162622 | Pentraxin 3 as a clinical marker in children with lower respiratory tract infection. |
| Q43992427 | Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children |
| Q84682599 | Pentraxin 3 increase is much less pronounced than C-reactive protein increase after surgical procedures |
| Q36889123 | Pentraxin 3: an immuno-regulator in the lungs |
| Q40313198 | Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease |
| Q34988829 | Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome |
| Q40096940 | Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients |
| Q53614316 | Redox proteomic analysis of serum from aortic anerurysm patients: insights on oxidation of specific protein target. |
| Q34119510 | Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. |
| Q37959060 | Role of C-reactive protein in cerebrovascular disease: a critical review |
| Q89451313 | Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits |
| Q42573978 | Serum pentraxin 3 concentrations in neonates |
| Q47707970 | Structure-activity relationships in Toll-like receptor 7 agonistic 1H-imidazo[4,5-c]pyridines |
| Q34394100 | Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-c]pyridines. |
| Q59136382 | The Development of Serum Amyloid P as a Possible Therapeutic |
| Q38504850 | The bovine milk proteome: cherishing, nourishing and fostering molecular complexity. An interactomics and functional overview. |
| Q26738957 | The inflammatory protein Pentraxin 3 in cardiovascular disease |
| Q33632041 | The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling |
| Q92239205 | Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury |
| Q38149507 | Vein graft failure |
| Q92740632 | Zebrafish C-reactive protein isoforms inhibit SVCV replication by blocking autophagy through interactions with cell membrane cholesterol |
| Q95402489 | [Correlation between pathogen-associated molecular patterns and periodontitis] |
Search more.